China Universal Asset Management »

SPDR S&P Biotech shares owned by China Universal Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 35k 94.90
2023-12-31 $795k 8.9k 89.29
2023-09-30 $650k 8.9k 73.00
2023-06-30 $741k 8.9k 83.22
2023-03-31 $12k 154 77.92
2022-12-31 $1.4M 17k 83.01
2022-09-30 $187k 2.4k 79.20

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Susquehanna International
Citigroup
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Wells Fargo & Company
Barclays

View all funds holding SPDR S&P Biotech